At present, clinical trials are under way with patients with Hepatitis C and a control group (University of Medicine & Dentistry of New Jersey IRB Protocol No. 0120090320). The purpose of the clinical trial is to identify patients who have low ROX and low BOX levels and examine their progress during the course of treatment with interferon and ribavirin supplements. |